Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
8.52×10-07
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.00341
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Glycerol
|
HET
|
7f:11m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.886
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
2f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.160
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HET
|
4f:12m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.228
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.389
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:12m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.622
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Simplified IPGTT / Blood glucose concentration
|
HET
|
50f:85m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
2f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0739
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Free fatty acids
|
HET
|
7f:11m
|
Linear Mixed Model framework, LME, including Weight
|
0.264
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
2f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.149
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Total cholesterol
|
HET
|
8f:12m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.346
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HET
|
8f:12m
|
Linear Mixed Model framework, LME, including Weight
|
0.0892
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Fasted Clinical Chemistry / Glucose
|
HET
|
2f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.825
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.726
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.263
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.325
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.472
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000661
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.224
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Urea
|
HET
|
3f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.366
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.348
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.509
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
8f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.186
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
3f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.893
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.874
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.963
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.847
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.160
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.626
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0382
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
6.30×10-05
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0507
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0892
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
5.83×10-06
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
1.44×10-15
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
7.62×10-11
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
DEXA / Fat/Body weight
|
HET
|
10f:17m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.339
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
DEXA / Fat mass
|
HET
|
10f:17m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.201
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0775
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.320
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Calorimetry / Carbon dioxide production
|
HET
|
456f:1381m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.339
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Triglyceride
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.464
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Calorimetry / Oxygen consumption
|
HET
|
456f:1381m
|
|
|
NotProcessed |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.192
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.256
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Dysmorphology / fat distribution
|
HET
|
13f:17m
|
|
|
NotProcessed |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
5.14×10-05
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000325
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
4.80×10-06
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.702
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00102
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00318
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.293
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.288
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.634
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.524
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00478
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0271
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.358
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.443
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
|
|
NotProcessed |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.370
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.803
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.621
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.994
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0484
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.423
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.296
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.465
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.789
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:4m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.887
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
3f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0475
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:4m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0586
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:2m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
f:1m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
1f:m
|
|
|
NotProcessed |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
5f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.248
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
2f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.273
|
Successful |
Tulp3hhkr
|
MRC Harwell
|
Simplified IPGTT / Glucose response AUC
|
HET
|
10f:17m
|
Linear Mixed Model framework, LME, including Weight
|
0.875
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.134
|
Successful |
Tulp3tm1b(EUCOMM)Hmgu
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.893
|
Successful |